Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 May 25

PMID 38792122

Authors

Kevin Y Wu

Xingao C Wang

Maude Anderson

Simon D Tran

Affiliations

Soon will be listed here.

Abstract

The eye's complex anatomical structures present formidable barriers to effective drug delivery across a range of ocular diseases, from anterior to posterior segment pathologies. Emerging as a promising solution to these challenges, nanotechnology-based platforms-including but not limited to liposomes, dendrimers, and micelles-have shown the potential to revolutionize ophthalmic therapeutics. These nanocarriers enhance drug bioavailability, increase residence time in targeted ocular tissues, and offer precise, localized delivery, minimizing systemic side effects. Focusing on pediatric ophthalmology, particularly on retinoblastoma, this review delves into the recent advancements in functionalized nanosystems for drug delivery. Covering the literature from 2017 to 2023, it comprehensively examines these nanocarriers' potential impact on transforming the treatment landscape for retinoblastoma. The review highlights the critical role of these platforms in overcoming the unique pediatric eye barriers, thus enhancing treatment efficacy. It underscores the necessity for ongoing research to realize the full clinical potential of these innovative drug delivery systems in pediatric ophthalmology.

References

Alkatan H, Al Marek F, Elkhamary S . Demographics of Pediatric Orbital Lesions: A Tertiary Eye Center Experience in Saudi Arabia. J Epidemiol Glob Health. 2019; 9(1):3-10. PMC: 7310758. DOI: 10.2991/jegh.k.181224.001. View

Alsaab H, Alzhrani R, Kesharwani P, Sau S, Boddu S, Iyer A . Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma. Pharmaceutics. 2017; 9(2). PMC: 5489932. DOI: 10.3390/pharmaceutics9020015. View

Hong S, Choi D, Kim H, Park C, Lee W, Park H . Protein-Based Nanoparticles as Drug Delivery Systems. Pharmaceutics. 2020; 12(7). PMC: 7407889. DOI: 10.3390/pharmaceutics12070604. View

Buzea C, Pacheco I, Robbie K . Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2010; 2(4):MR17-71. DOI: 10.1116/1.2815690. View

Mattosinho C, Moura A, Oigman G, Ferman S, Grigorovski N . Time to diagnosis of retinoblastoma in Latin America: A systematic review. Pediatr Hematol Oncol. 2019; 36(2):55-72. DOI: 10.1080/08880018.2019.1605432. View

Mudigunda S, Pemmaraju D, Sankaranarayanan S, Rengan A . Bioactive Polymeric Nanoparticles of Induced Phyto-Photothermal Sensitization for the Enhanced Therapy of Retinoblastoma. Pharmaceutics. 2023; 15(2). PMC: 9965703. DOI: 10.3390/pharmaceutics15020475. View

Delrish E, Jabbarvand M, Ghassemi F, Amoli F, Atyabi F, Heidari Keshel S . The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model. J Ophthalmic Vis Res. 2023; 18(1):68-80. PMC: 10020795. DOI: 10.18502/jovr.v18i1.12727. View

Delrish E, Ghassemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M . Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma. J Ophthalmic Vis Res. 2022; 17(1):58-68. PMC: 8850845. DOI: 10.18502/jovr.v17i1.10171. View

Boedtkjer E, Pedersen S . The Acidic Tumor Microenvironment as a Driver of Cancer. Annu Rev Physiol. 2019; 82:103-126. DOI: 10.1146/annurev-physiol-021119-034627. View

10.

Kim J, Park Y . Treatment of Retinoblastoma: The Role of External Beam Radiotherapy. Yonsei Med J. 2015; 56(6):1478-91. PMC: 4630033. DOI: 10.3349/ymj.2015.56.6.1478. View

11.

Abdullah L, Chow E . Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013; 2(1):3. PMC: 3565873. DOI: 10.1186/2001-1326-2-3. View

12.

Pucci C, DeglInnocenti A, Belenli Gumus M, Ciofani G . Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era. Biomater Sci. 2022; 10(9):2103-2121. DOI: 10.1039/d1bm01963e. View

13.

Marathe S, Shadambikar G, Mehraj T, Sulochana S, Dudhipala N, Majumdar S . Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel. Pharmaceutics. 2022; 14(5). PMC: 9145488. DOI: 10.3390/pharmaceutics14051034. View

14.

Hu X, Zhang D, Huang L, Zeng Z, Su Y, Chen S . Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics. ACS Biomater Sci Eng. 2024; 10(3):1830-1842. DOI: 10.1021/acsbiomaterials.3c01972. View

15.

Moradi S, Mokhtari-Dizaji M, Ghassemi F, Sheibani S, Amoli F . Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model. Int J Radiat Biol. 2020; 96(12):1614-1627. DOI: 10.1080/09553002.2020.1838657. View

16.

Wang M, Yang Q, Li M, Zou H, Wang Z, Ran H . Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy. ACS Appl Mater Interfaces. 2020; 12(5):5642-5657. DOI: 10.1021/acsami.9b22072. View

17.

Mudigunda S, Pemmaraju D, Paradkar S, Puppala E, Gawali B, Upadhyayula S . Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma. ACS Biomater Sci Eng. 2021; 8(1):151-160. DOI: 10.1021/acsbiomaterials.1c01234. View

18.

Yan S, Yan J, Liu D, Li X, Kang Q, You W . A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity. Theranostics. 2021; 11(14):6833-6846. PMC: 8171083. DOI: 10.7150/thno.59020. View

19.

Darviot C, Hardy P, Meunier M . Laser-induced plasmon-mediated treatment of retinoblastoma in viscous vitreous phantom. J Biophotonics. 2019; 12(11):e201900193. DOI: 10.1002/jbio.201900193. View

20.

Abramson D, FRANK C . Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology. 1998; 105(4):573-9; discussion 579-80. DOI: 10.1016/S0161-6420(98)94006-4. View